Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Item

http://www.wikidata.org/entity/Q40373192

Q40373192

about

Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy.

P2860

Q47094576-DB04C56B-C738-4C00-9E54-3829758C41D5 Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90 Q51773142-7056F22C-C8AC-4BDF-9691-29D7EF10320A

P2860

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Item

http://www.wikidata.org/entity/Q40373192

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Addition of cladribine to the ...... a Group (PALG) phase II trial.

@en

type

Item

label

Addition of cladribine to the ...... a Group (PALG) phase II trial.

@en

prefLabel

Addition of cladribine to the ...... a Group (PALG) phase II trial.

@en

P1476

Addition of cladribine to the ...... ia Group (PALG) phase II trial

@en

P2093

Agata Wrzesien-Kus

http://www.w3.org/2001/XMLSchema#string

Agnieszka Pluta

http://www.w3.org/2001/XMLSchema#string

Aleksandra Butrym

http://www.w3.org/2001/XMLSchema#string

Aleksandra Golos

http://www.w3.org/2001/XMLSchema#string

Aleksandra Holowiecka-Goral

http://www.w3.org/2001/XMLSchema#string

Bozena Katarzyna Budziszewska

http://www.w3.org/2001/XMLSchema#string

Ewa Wawrzyniak

http://www.w3.org/2001/XMLSchema#string

Janusz Kloczko

http://www.w3.org/2001/XMLSchema#string

Jerzy Holowiecki

http://www.w3.org/2001/XMLSchema#string

Kazimierz Kuliczkowski

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.

High-dose daunorubicin in older patients with acute myeloid leukemia.

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.

Acute myeloid leukemia in the real world: why population-based registries are needed.

P304

359-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24654

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard Szydlo

Krzysztof Warzocha

Jaroslaw Piszcz

Agnieszka Wierzbowska

A Lange

Sebastian Grosicki

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28103640

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

phase II clinical trial

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

about

P2860

P2860

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921